Hypertension and Hypertrophic Cardiomyopathy

Authors

Bipul Baibhav, Rochester Regional HealthFollow
Andrew Wang

Editor

Naidu, S.S.

Department

Cardiology

Document Type

Book Chapter

Publication Title

Hypertrophic Cardiomyopathy

Abstract

Across the age spectrum of hypertrophic cardiomyopathy (HCM), hypertension (HTN) is a common, comorbid condition in approximately half of all HCM patients. HCM and hypertensive cardiomyopathy lead to similar structural abnormalities in the myocardium, but these changes are generally more prominent in HCM. A composite of clinical variables may be used to differentiate these conditions. The appropriate treatment of HTN in HCM is not well defined, and recommendations for use of drugs with blood pressure-lowering effects have focused largely on the potential for exacerbating left ventricular outflow obstruction by reducing preload or afterload, rather than clinical endpoints used in outcome studies of HTN and HCM therapies.

First Page

261

Last Page

271

DOI

10.1007/978-3-031-99282-7_19

Publication Date

11-16-2025

Publisher

Springer, Cham

Comments

ISBN: 978-3-031-99281-0

Recommended Citation

Baibhav, B., & Wang, A. (2025). Hypertension and Hypertrophic Cardiomyopathy. Hypertrophic Cardiomyopathy, 261-271. https://doi.org/10.1007/978-3-031-99282-7_19